PhD: Indian Institute of Science,
MSc: Osmania University,
Molecular and cellular processes underlying the protective and detrimental immune responses in acute and chronic pancreatitis; underlying factors driving unresolved inflammation, fibrosis, immune suppression, and the development of pancreatic cancer.
Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited T cells in patients with metastatic colorectal cancer: a first-in-human, single-centre, phase 1 trial. The Lancet Oncology. 2025; 26(5):559-570.
Abstract A033: Blocking TNF-a producing macrophage activates antitumor immunity in pancreatic cancer via IL33. Cancer Research. 2024; 84(2_Supplement):a033-a033.
Targeting TNF-α-producing macrophages activates antitumor immunity in pancreatic cancer via IL-33 signaling. JCI Insight. 2022; 7(22).
Immune Cell Metabolism and Function. In: Immuno-Oncology Crosstalk and Metabolism. Springer Nature; 2022:1-20.
Loss of HIF1A From Pancreatic Cancer Cells Increases Expression of PPP1R1B and Degradation of p53 to Promote Invasion and Metastasis. Gastroenterology. 2020; 159(5):1882-1897.e5.
Tu1361 Extracellular ATP Promotes Systemic Inflammation During Acute Pancreatitis. Gastroenterology. 2017; 152(5):s896.
Tu1352 Naltrexone as a Disease Modifying Therapy in a Mouse Model of Chronic Pancreatitis. Gastroenterology. 2017; 152(5):s893-s894.
Tu1353 Pathogenesis of Chronic Pancreatitis is Independent of Trypsin Activation in L-Arginine Induced Mouse Model of Disease. Gastroenterology. 2017; 152(5):s894.
Tu1494 Minnelide Reduces Pancreatic Atrophy, Fibrosis and Inflammation in Murine Models of Chronic Pancreatitis. Gastroenterology. 2016; 150(4):s916.
Sa1485 Morphine Worsens Pancreatic Injury in Models of Recurrent Acute Pancreatitis. Gastroenterology. 2016; 150(4):s328.